Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-1|1|0|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-2|1|44|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-3|1|336|Other deterministic changes|Whole body|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-4|1|336|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastases in lung|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-5|1|363|Neoplasia malignant|Lower respiratory system|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-6|1|388|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-7|1|391|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-8|1|393|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-9|1|408|Neoplasia malignant|Lower respiratory system| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-10|1|421|Other deterministic changes|Whole body|missing|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring 
|7-5-1-11|1|422|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-12|1|441|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-13|1|460|Neoplasia malignant|Lower respiratory system| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-14|1|478|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-15|1|501|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-16|1|511|Neoplasia malignant|Lower respiratory system|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-17|1|514|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-18|1|532|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-19|1|532|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-20|1|549|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-21|1|553|Other deterministic changes|Whole body| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-22|1|567|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-23|1|570|Hyperplastic changes|Hepato-pancreatic system,MA: 0000358 - liver|,MPATH: 484 - hyperplastic nodule|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-24|1|575|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-25|1|578|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-26|1|582|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-27|1|585|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-28|1|597|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-29|1|600|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-30|1|601|Neoplasia benign|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-31|1|602|Hyperplastic changes|Hepato-pancreatic system,MA: 0000358 - liver|,MPATH: 484 - hyperplastic nodule|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-32|1|606|Neoplasia malignant|Lower respiratory system| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-33|1|607|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-34|1|608|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-35|1|611|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-36|1|613|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-37|1|615|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-38|1|616|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|seminal vesicle abscess|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-39|1|624|Other deterministic changes|Whole body| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-40|1|624|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-41|1|626|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-42|1|627|Neoplasia benign|Endocrine system|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-43|1|631|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-44|1|636|Neoplasia malignant|Lower respiratory system| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-45|1|637|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-46|1|638|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|chronic pancreatitis|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-47|1|647|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-48|1|661|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-49|1|674|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-50|1|679|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-51|1|681|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-52|1|683|Neoplasia benign|Lower digestive tract,MA: 0000328 - intestine|polypoid,MPATH: 270 - adenoma|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-53|1|683|Other deterministic changes|Whole body| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-54|1|690|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-55|1|690|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-56|1|695|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-57|1|697|Neoplasia benign|Liver among hepato-pancreatic system diseases|lymphocytosis|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-58|1|697|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-59|1|707|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-60|1|709|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-61|1|715|Other deterministic changes|Whole body| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-62|1|715|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-63|1|721|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-64|1|721|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-65|1|722|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-66|1|731|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-67|1|732|Neoplasia benign|Liver among hepato-pancreatic system diseases|necrotic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-68|1|734|Neoplasia malignant|Lower respiratory system|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-69|1|735|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|doubtful origin metastatic lung,MPATH: 218 - neoplasm|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-70|1|737|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-71|1|738|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-72|1|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-73|1|742|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-74|1|744|Other deterministic changes|Bone among musculo-skeletal system diseases|osteoneogenesis focal|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-75|1|749|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-76|1|749|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-77|1|751|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-78|1|751|Neoplasia malignant|Liver among hepato-pancreatic system diseases| metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-79|1|753|Other deterministic changes|Whole body|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-80|1|755|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-81|1|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-82|1|760|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-83|1|765|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-84|1|768|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-85|1|769|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-86|1|770|Neoplasia malignant|Bloodvessels among cardiovascular system| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-87|1|771|Neoplasia malignant|Liver among hepato-pancreatic system diseases| metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-88|1|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-89|1|776|Neoplasia unclassified|Nervous system and special sense organs| Paraganglioma|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-90|1|780|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-91|1|783|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-92|1|786|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-93|1|786|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-94|1|787|Neoplasia malignant|Bloodvessels among cardiovascular system| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-95|1|787|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-96|1|788|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-97|1|789|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-98|1|789|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-99|1|797|Neoplasia unclassified|Peripheral nerves  among nervous system|malignant|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-100|1|798|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-101|1|798|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-102|1|801|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-103|1|803|Neoplasia malignant|Liver among hepato-pancreatic system diseases| multiple metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-104|1|808|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-105|1|811|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-106|1|815|Other deterministic changes|Bone among musculo-skeletal system diseases|osteoproliferative lesion tumor ?|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-107|1|816|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-108|1|820|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-109|1|820|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-110|1|821|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-111|1|822|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-112|1|823|Other deterministic changes|Whole body|missing|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-113|1|824|Hyperplastic changes|Hepato-pancreatic system,MA: 0000358 - liver| eosinophilic, basophilic,MPATH: 484 - hyperplastic nodule|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-114|1|824|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle|,MPATH: 268 - adenocarcinoma|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-115|1|826|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastatic anaplastic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-116|1|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-117|1|834|Neoplasia malignant|Bloodvessels among cardiovascular system| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-118|1|835|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-119|1|836|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-120|1|842|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-121|1|844|Neoplasia malignant|Liver among hepato-pancreatic system diseases| metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-122|1|849|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-123|1|850|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-124|1|851|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-125|1|851|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|early,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-126|1|854|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-127|1|856|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-128|1|856|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|plasmocytic,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-129|1|857|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-130|1|857|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-131|1|857|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-132|1|859|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-133|1|862|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-134|1|863|Neoplasia malignant|Lower respiratory system|anaplastic metastatic blood carcinomatosis (monocy|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-135|1|863|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-136|1|864|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-137|1|867|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-138|1|870|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-139|1|870|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-140|1|871|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-141|1|875|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-142|1|876|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-143|1|879|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-144|1|880|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-145|1|880|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-146|1|885|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-147|1|888|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-148|1|889|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-149|1|895|Neoplasia malignant|Lower respiratory system|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-150|1|895|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-151|1|897|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-152|1|898|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-153|1|898|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-154|1|900|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-155|1|900|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-156|1|905|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-157|1|909|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-158|1|911|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-159|1|911|Other deterministic changes|Whole body| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-160|1|913|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-161|1|914|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-162|1|916|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-163|1|917|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-164|1|921|Other deterministic changes|Whole body|missing|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-165|1|924|Neoplasia unclassified|Nervous system and special sense organs|Paraganglioma|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-166|1|925|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-167|1|928|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-168|1|930|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|Harderian gland check code|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-169|1|932|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-170|1|934|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-171|1|934|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system| epicardial,MPATH: 181 - fibrosis|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-172|1|935|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-173|1|936|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-174|1|937|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-175|1|939|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-176|1|945|Neoplasia malignant|Lower respiratory system| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-177|1|949|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-178|1|953|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-179|1|955|Neoplasia unclassified|Nervous system and special sense organs| Prostate malignant paraganglioma|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-180|1|957|Other deterministic changes|Whole body|missing|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-181|1|959|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-182|1|962|Other deterministic changes|Whole body|missing|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-183|1|962|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-184|1|962|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-185|1|976|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-186|1|979|Other deterministic changes|Whole body|missing|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-187|1|981|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-188|1|981|Other deterministic changes|Whole body|missing|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-189|1|987|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-190|1|989|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-191|1|999|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-192|1|1001|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cell,MPATH: 513 - Lymphoid neoplasms|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-193|1|1016|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-194|1|1033|Neoplasia benign|Bloodvessels among cardiovascular system| |
7-5-1|Pu-13d-Bq 16,PLC 2|1| -7|Pu-239 citrate|16|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|194 (195 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-1-195|1|n/a|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-1|2|156|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-2|2|325|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-3|2|422|Neoplasia malignant|Lower respiratory system| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-4|2|429|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-5|2|430|Neoplasia benign|Liver among hepato-pancreatic system diseases|early|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-6|2|448|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-7|2|463|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-8|2|464|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus| cystitis|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-9|2|465|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-10|2|472|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-11|2|482|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-12|2|488|Other deterministic changes|Whole body| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-13|2|512|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-14|2|522|Neoplasia malignant|Lower respiratory system| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-15|2|527|Other deterministic changes|Whole body| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-16|2|527|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-17|2|531|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-18|2|552|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-19|2|561|Neoplasia benign|Lower digestive tract,MA: 0000328 - intestine|,MPATH: 270 - adenoma|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-20|2|566|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-21|2|567|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-22|2|567|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-23|2|575|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-24|2|593|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-25|2|593|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-26|2|595|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-27|2|596|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-28|2|605|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-29|2|605|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-30|2|607|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-31|2|613|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-32|2|616|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-33|2|622|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-34|2|628|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-35|2|635|Neoplasia benign|Liver among hepato-pancreatic system diseases|basophilic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-36|2|638|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-37|2|638|Neoplasia malignant|Lower respiratory system| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-38|2|646|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-39|2|650|Neoplasia malignant|Lower digestive tract,MA: 0000328 - intestine| ,MPATH: 549 - carcinoma|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-40|2|651|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-41|2|667|Neoplasia benign|Lower respiratory system| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-42|2|674|Neoplasia malignant|Bloodvessels among cardiovascular system| metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-43|2|674|Neoplasia malignant|Lower respiratory system| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-44|2|678|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-45|2|679|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-46|2|681|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-47|2|682|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-48|2|688|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-49|2|695|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-50|2|699|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-51|2|703|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-52|2|705|Neoplasia malignant|Lower respiratory system| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-53|2|709|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-54|2|715|Other deterministic changes|Whole body| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-55|2|715|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-56|2|719|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-57|2|719|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-58|2|722|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-59|2|723|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-60|2|724|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-61|2|732|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-62|2|734|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-63|2|738|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-64|2|740|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-65|2|742|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-66|2|744|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-67|2|748|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-68|2|753|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic lung|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-69|2|758|Neoplasia benign|Lower respiratory system|multiple|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-70|2|760|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|plasmocytes,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-71|2|761|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-72|2|763|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-73|2|764|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-74|2|766|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-75|2|769|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-76|2|769|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-77|2|771|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-78|2|771|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-79|2|773|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-80|2|775|Neoplasia malignant|Lower respiratory system|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-81|2|775|Neoplasia malignant|Endocrine system|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-82|2|777|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-83|2|779|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-84|2|783|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-85|2|785|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-86|2|787|Other deterministic changes|Whole body| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-87|2|790|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-88|2|791|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-89|2|803|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-90|2|806|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-91|2|809|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-92|2|810|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-93|2|814|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-94|2|814|Other deterministic changes|Whole body| missing|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-95|2|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-96|2|819|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-97|2|823|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-98|2|823|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-99|2|826|Other deterministic changes|Whole body|missing|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-100|2|827|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-101|2|833|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-102|2|835|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-103|2|837|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-104|2|838|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-105|2|840|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-106|2|841|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-107|2|844|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-108|2|845|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-109|2|845|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-110|2|848|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-111|2|855|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-112|2|856|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-113|2|856|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-114|2|859|Neoplasia malignant|Lower respiratory system| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-115|2|865|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-116|2|867|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-117|2|868|Neoplasia malignant|Liver among hepato-pancreatic system diseases|carcinoid metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-118|2|868|Other deterministic changes|Whole body| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-119|2|870|Neoplasia benign|Lower respiratory system|hyperplastic focus|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-120|2|871|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-121|2|873|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-122|2|875|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-123|2|876|Other deterministic changes|Whole body| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-124|2|883|Neoplasia malignant|Spleen and thymus  among haematolymphatic system| benign|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-125|2|884|Neoplasia benign|Liver among hepato-pancreatic system diseases|eosinophilic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-126|2|895|Other deterministic changes|Whole body|missing|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-127|2|901|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-128|2|901|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-129|2|908|Hyperplastic changes|Hepato-pancreatic system,MA: 0000358 - liver|eosinophilic,MPATH: 484 - hyperplastic nodule|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-130|2|910|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-131|2|915|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-132|2|915|Other deterministic changes|Whole body|missing|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-133|2|917|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-134|2|929|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-135|2|937|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-136|2|937|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-137|2|944|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-138|2|950|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-139|2|953|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-140|2|955|Other deterministic changes|Whole body|missing|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-141|2|960|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-142|2|962|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-143|2|963|Other deterministic changes|Whole body|missing|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-144|2|980|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-145|2|980|Other deterministic changes|Whole body|missing|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-146|2|981|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-147|2|981|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-148|2|982|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-149|2|982|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-150|2|982|Other deterministic changes|Whole body|missing|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-151|2|989|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-152|2|995|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-153|2|995|Other deterministic changes|Whole body| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-154|2|998|Other deterministic changes|Whole body|missing|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-155|2|1000|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-156|2|1006|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-157|2|1022|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|missing,MPATH: 268 - adenocarcinoma|
7-5-2|Pu-4d-Bq 32,PLC 3|1| -7|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|158 (158 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-2-158|2|1025|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-1|3|220|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-2|3|275|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-3|3|307|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-4|3|316|Other deterministic changes|Lower digestive tract|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-5|3|352|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-6|3|364|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-7|3|401|Neoplasia malignant|Liver among hepato-pancreatic system diseases| metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-8|3|412|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-9|3|416|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-10|3|416|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-11|3|422|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-12|3|431|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-13|3|445|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-14|3|446|Neoplasia unclassified|Peripheral nerves  among nervous system| malignant|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-15|3|455|Neoplasia benign|Liver among hepato-pancreatic system diseases|focal lung|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-16|3|466|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-17|3|482|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-18|3|486|Neoplasia malignant|Liver among hepato-pancreatic system diseases|basophilic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-19|3|515|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-20|3|523|Neoplasia malignant|Lower respiratory system| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-21|3|527|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-22|3|530|Neoplasia malignant|Liver among hepato-pancreatic system diseases|focal medullary osteogenesis|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-23|3|533|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-24|3|538|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-25|3|542|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-26|3|546|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-27|3|548|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-28|3|551|Other deterministic changes|Whole body|missing|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-29|3|551|Neoplasia malignant|Lower respiratory system| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-30|3|552|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-31|3|564|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|kidney|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-32|3|569|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-33|3|570|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-34|3|574|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-35|3|581|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-36|3|587|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-37|3|587|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-38|3|597|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-39|3|597|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-40|3|598|Other deterministic changes|Whole body|missing|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-41|3|599|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-42|3|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-43|3|602|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-44|3|602|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-45|3|609|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus| abscess Harderian|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-46|3|615|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-47|3|641|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-48|3|642|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-49|3|648|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-50|3|649|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-51|3|649|Neoplasia malignant|Lower respiratory system| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-52|3|649|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-53|3|652|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|abscess eye?|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-54|3|656|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-55|3|660|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-56|3|661|Neoplasia unclassified|Nervous system and special sense organs|malignant|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-57|3|662|Neoplasia malignant|Bone among musculo-skeletal system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-58|3|672|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-59|3|672|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-60|3|672|Inflammation and/or fibrotic diseases|Kidney among urinary system diseases,MA: 0000368 - kidney| severe hydronephrosis,MPATH: 212 - inflammation|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-61|3|674|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-62|3|677|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-63|3|678|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-64|3|678|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-65|3|684|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-66|3|684|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-67|3|685|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-68|3|685|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-69|3|689|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-70|3|691|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-71|3|691|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| pleomorphic could be histiocytic,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-72|3|693|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-73|3|694|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-74|3|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-75|3|702|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-76|3|703|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-77|3|708|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-78|3|710|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-79|3|711|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-80|3|712|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-81|3|715|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-82|3|715|Neoplasia malignant|Bloodvessels among cardiovascular system| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-83|3|716|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-84|3|717|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-85|3|726|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-86|3|728|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-87|3|732|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|aspiration pneumonia,MPATH: 212 - inflammation|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-88|3|732|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-89|3|736|Neoplasia benign|Liver among hepato-pancreatic system diseases|muscle fat necrosis|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-90|3|746|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-91|3|747|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-92|3|747|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system| kidney focal tunica muscularis,MPATH: 181 - fibrosis|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-93|3|750|Other deterministic changes|Whole body|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-94|3|755|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-95|3|755|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-96|3|757|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-97|3|758|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-98|3|763|Neoplasia benign|Liver among hepato-pancreatic system diseases|basophilic foci|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-99|3|764|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-100|3|776|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-101|3|777|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney| ,MPATH: 549 - carcinoma|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-102|3|778|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-103|3|780|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-104|3|785|Other deterministic changes|Lower respiratory system|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-105|3|789|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-106|3|794|Neoplasia malignant|Lower respiratory system| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-107|3|796|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-108|3|802|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-109|3|803|Neoplasia malignant|Lower respiratory system| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-110|3|805|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-111|3|807|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-112|3|808|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|early,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-113|3|809|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-114|3|809|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-115|3|811|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-116|3|812|Other deterministic changes|Whole body|missing|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-117|3|813|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000356 - gall bladder| ,MPATH: 268 - adenocarcinoma|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-118|3|815|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-119|3|816|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-120|3|818|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-121|3|818|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-122|3|819|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-123|3|821|Neoplasia benign|Lower digestive tract,MA: 0000328 - intestine|polypoid,MPATH: 270 - adenoma|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-124|3|823|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-125|3|827|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-126|3|828|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|aspiration pneumonia,MPATH: 212 - inflammation|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-127|3|830|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-128|3|830|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-129|3|831|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-130|3|834|Other deterministic changes|Whole body|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-131|3|834|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-132|3|837|Neoplasia malignant|Lower respiratory system| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-133|3|838|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|skin ulceration|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-134|3|840|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-135|3|840|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-136|3|842|Neoplasia malignant|Lower respiratory system| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-137|3|843|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-138|3|845|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-139|3|848|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-140|3|849|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-141|3|850|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-142|3|850|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-143|3|851|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-144|3|859|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-145|3|863|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|cystitis|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-146|3|870|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-147|3|873|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|intest. Ulceration|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-148|3|874|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-149|3|878|Other deterministic changes|Whole body|missing|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-150|3|879|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-151|3|881|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-152|3|884|Other deterministic changes|Whole body|missing|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-153|3|885|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-154|3|886|Hyperplastic changes|Other local manifestations and miscellaneus|lymphoepithial proliferation (non-neoplastic) paro|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-155|3|886|Other deterministic changes|Whole body| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-156|3|887|Neoplasia malignant|Lower respiratory system| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-157|3|887|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-158|3|887|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-159|3|887|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-160|3|888|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-161|3|890|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-162|3|895|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-163|3|895|Other deterministic changes|Whole body|missing|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-164|3|895|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-165|3|896|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-166|3|901|Neoplasia benign|Kidney among urinary system diseases,MA: 0000368 - kidney|multiple,MPATH: 270 - adenoma|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-167|3|902|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-168|3|910|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-169|3|915|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-170|3|916|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-171|3|917|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-172|3|918|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-173|3|926|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-174|3|930|Other deterministic changes|Whole body| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-175|3|934|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-176|3|948|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-177|3|948|Neoplasia unclassified|Nervous system and special sense organs|neuroendocrine tumor prostate|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-178|3|951|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-179|3|951|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-180|3|952|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-181|3|956|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-182|3|957|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-183|3|960|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-184|3|960|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-185|3|964|Neoplasia malignant|Lower respiratory system| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-186|3|965|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-187|3|970|Neoplasia unclassified|Nervous system and special sense organs|malignant paraganglioma|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-188|3|976|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-189|3|982|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-190|3|983|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-191|3|985|Neoplasia benign|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-192|3|989|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-193|3|1001|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|autolysed,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-194|3|1001|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-195|3|1011|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic multiple|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-196|3|1013|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-197|3|1013|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-198|3|1017|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-199|3|1028|Other deterministic changes|Whole body| |
7-5-3|Pu-13d-Bq 32,PLC 4|1| -13|Pu-239 citrate|32|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-3-200|3|1116|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-1|4|191|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-2|4|240|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-3|4|391|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-4|4|445|Neoplasia malignant|Lower respiratory system| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-5|4|448|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-6|4|451|Neoplasia malignant|Bloodvessels among cardiovascular system| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-7|4|457|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-8|4|458|Neoplasia benign|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-9|4|467|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-10|4|472|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-11|4|498|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-12|4|505|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-13|4|522|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-14|4|528|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-15|4|537|Neoplasia malignant|Lower respiratory system|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-16|4|539|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-17|4|541|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-18|4|541|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-19|4|544|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|early,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-20|4|545|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-21|4|549|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-22|4|553|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-23|4|558|Neoplasia malignant|Bloodvessels among cardiovascular system| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-24|4|559|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-25|4|560|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-26|4|560|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-27|4|562|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-28|4|566|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-29|4|567|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-30|4|571|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-31|4|578|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-32|4|579|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-33|4|580|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-34|4|583|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-35|4|584|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-36|4|589|Neoplasia malignant|Liver among hepato-pancreatic system diseases| focal osteogenesis|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-37|4|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-38|4|597|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-39|4|598|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-40|4|599|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-41|4|600|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-42|4|608|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-43|4|609|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-44|4|611|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-45|4|613|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-46|4|614|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-47|4|619|Neoplasia malignant|Lower respiratory system| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-48|4|622|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-49|4|625|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-50|4|628|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-51|4|631|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-52|4|633|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-53|4|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-54|4|636|Neoplasia benign|Bloodvessels among cardiovascular system|vacular hamartoma|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-55|4|640|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-56|4|640|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-57|4|648|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-58|4|652|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-59|4|653|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-60|4|661|Acute infections|Lower digestive tract,MA: 0000054 - peritoneal cavity| pyogranumulous ulceration,MPATH: 212 - inflammation|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-61|4|661|Neoplasia malignant|Lower respiratory system| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-62|4|666|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-63|4|667|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-64|4|669|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-65|4|674|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-66|4|675|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-67|4|681|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-68|4|685|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|skin abscess|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-69|4|689|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-70|4|691|Other deterministic changes|Whole body|missing|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-71|4|692|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-72|4|695|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-73|4|699|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-74|4|701|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-75|4|702|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-76|4|715|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-77|4|715|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-78|4|718|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|metastatic,MPATH: 408 - soft tissue fibrosarcoma|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-79|4|727|Neoplasia malignant|Lower respiratory system| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-80|4|732|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-81|4|734|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-82|4|736|Neoplasia malignant|Endocrine system|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-83|4|737|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-84|4|739|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-85|4|739|Neoplasia benign|Lower respiratory system|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-86|4|741|Neoplasia malignant|Lower respiratory system| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-87|4|742|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-88|4|743|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-89|4|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| large cells undifferenciated,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-90|4|745|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-91|4|747|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-92|4|747|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-93|4|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-94|4|756|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-95|4|761|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|early,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-96|4|762|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-97|4|762|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-98|4|763|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-99|4|764|Neoplasia malignant|Lower respiratory system| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-100|4|766|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-101|4|772|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-102|4|773|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-103|4|773|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-104|4|774|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-105|4|778|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-106|4|780|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-107|4|782|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-108|4|782|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-109|4|785|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-110|4|793|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-111|4|793|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-112|4|794|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-113|4|795|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-114|4|797|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-115|4|800|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-116|4|807|Inflammation and/or fibrotic diseases|Nervous system and special sense organs,MA: 0001113 - meninges|suppurative,MPATH: 212 - inflammation|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-117|4|810|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-118|4|814|Other deterministic changes|Whole body| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-119|4|815|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-120|4|818|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-121|4|819|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-122|4|821|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-123|4|821|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-124|4|823|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-125|4|823|Neoplasia benign|Lower respiratory system|hyperplastic form|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-126|4|825|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|kidney, salivary gland|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-127|4|825|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-128|4|833|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-129|4|833|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-130|4|834|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-131|4|835|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-132|4|837|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-133|4|840|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-134|4|840|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-135|4|840|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-136|4|847|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-137|4|849|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-138|4|850|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-139|4|859|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-140|4|860|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-141|4|866|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-142|4|868|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-143|4|871|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-144|4|875|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-145|4|875|Neoplasia unclassified|Nervous system and special sense organs|paraganglioma malignant mesenterium|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-146|4|878|Other deterministic changes|Whole body| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-147|4|879|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-148|4|881|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-149|4|882|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-150|4|887|Neoplasia malignant|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-151|4|893|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-152|4|897|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-153|4|898|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-154|4|903|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-155|4|905|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|salivary gland (myxomatous?),MPATH: 408 - soft tissue fibrosarcoma|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-156|4|913|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-157|4|921|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-158|4|925|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-159|4|928|Neoplasia benign|Endocrine system|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-160|4|934|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-161|4|940|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-162|4|943|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|ulceration small intestine|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-163|4|943|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-164|4|947|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-165|4|951|Neoplasia malignant|Lower respiratory system| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-166|4|951|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatiic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-167|4|951|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-168|4|960|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-169|4|961|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-170|4|965|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-171|4|968|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-172|4|977|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-173|4|979|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-174|4|979|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-175|4|979|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-176|4|985|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-177|4|991|Inflammation and/or fibrotic diseases|Nervous system and special sense organs,MA: 0001113 - meninges|suppurative,MPATH: 212 - inflammation|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-178|4|992|Neoplasia benign|Lower digestive tract,MA: 0000328 - intestine|polyp,MPATH: 270 - adenoma|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-179|4|997|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-180|4|1009|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-181|4|1010|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-182|4|1032|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-183|4|1034|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-184|4|1048|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-185|4|1049|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-186|4|1051|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-187|4|1065|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-188|4|1077|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-189|4|1079|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system| ,MPATH: 513 - Lymphoid neoplasms|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-190|4|1108|Other deterministic changes|Whole body| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-191|4|1108|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-192|4|1126|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-193|4|1136|Neoplasia malignant|Lower respiratory system| multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-194|4|1142|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-195|4|1147|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-196|4|1154|Neoplasia malignant|Liver among hepato-pancreatic system diseases| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-197|4|1164|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-198|4|1199|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-199|4|1203|Other deterministic changes|Whole body| |
7-5-4|Pu-4d-Bq 64,PLC 5|1| -7|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 13d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Organogenese|offspring|7-5-4-200|4|1227|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-1|5|49|Neoplasia unclassified|Peripheral nerves  among nervous system|highly malignant, metastatic possibly arising from|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-2|5|426|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-3|5|469|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-4|5|470|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-5|5|491|Neoplasia benign|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 270 - adenoma|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-6|5|519|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-7|5|524|Neoplasia malignant|Integumentary system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-8|5|539|Other deterministic changes|Whole body|missing|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-9|5|552|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-10|5|553|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-11|5|562|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-12|5|573|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-13|5|575|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-14|5|580|Other deterministic changes|Whole body|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-15|5|581|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-16|5|590|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-17|5|602|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-18|5|607|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-19|5|607|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|early,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-20|5|608|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-21|5|613|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|pleomorphic tumor,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-22|5|614|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-23|5|622|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|megakaryocytes or histiocytic?,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-24|5|639|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-25|5|644|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-26|5|648|Other deterministic changes|Whole body|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-27|5|649|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-28|5|649|Neoplasia malignant|Lower respiratory system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-29|5|649|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-30|5|650|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-31|5|651|Neoplasia benign|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 270 - adenoma|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-32|5|652|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|ulceration small intestine|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-33|5|653|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-34|5|657|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|ulceration small intestine|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-35|5|658|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-36|5|659|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-37|5|662|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-38|5|662|Neoplasia malignant|Lower respiratory system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-39|5|663|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-40|5|665|Other deterministic changes|Whole body|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-41|5|670|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-42|5|671|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-43|5|675|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-44|5|680|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-45|5|682|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-46|5|688|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-47|5|689|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-48|5|691|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-49|5|692|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-50|5|693|Other deterministic changes|Whole body|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-51|5|698|Other deterministic changes|Whole body|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-52|5|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-53|5|699|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-54|5|702|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-55|5|703|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-56|5|704|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-57|5|705|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-58|5|712|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-59|5|713|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-60|5|714|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-61|5|714|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-62|5|715|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-63|5|715|Hyperplastic changes|Hepato-pancreatic system,MA: 0000358 - liver|regenerative hyperplasia,MPATH: 484 - hyperplastic nodule|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-64|5|717|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-65|5|719|Other deterministic changes|Bone among musculo-skeletal system diseases|hydronephrosis|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-66|5|726|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-67|5|727|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-68|5|731|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-69|5|732|Neoplasia malignant|Endocrine system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-70|5|735|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-71|5|739|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-72|5|749|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-73|5|751|Neoplasia malignant|Liver among hepato-pancreatic system diseases|ulceration colon  + peritonitis|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-74|5|756|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-75|5|757|Neoplasia malignant|Lower respiratory system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-76|5|757|Neoplasia benign|Bloodvessels among cardiovascular system|skin|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-77|5|759|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-78|5|760|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-79|5|768|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells plasmocytic,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-80|5|772|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-81|5|772|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-82|5|774|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-83|5|776|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-84|5|778|Neoplasia malignant|Lower respiratory system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-85|5|780|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|lung abscess|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-86|5|783|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-87|5|783|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-88|5|786|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-89|5|788|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-90|5|789|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-91|5|791|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-92|5|791|Degenerative changes|Haematolymphatic system,MA: 0000134 - bone marrow|? Left shift myelodysplasia,MPATH: 127 - atrophy|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-93|5|791|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-94|5|791|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-95|5|792|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-96|5|793|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-97|5|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-98|5|800|Neoplasia malignant|Other local manifestations and miscellaneus|from sternum NOS giant cells|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-99|5|802|Neoplasia malignant|Lower respiratory system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-100|5|809|Other deterministic changes|Whole body|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-101|5|810|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-102|5|815|Neoplasia malignant|Other local manifestations and miscellaneus|NOS|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-103|5|823|Neoplasia malignant|Lower respiratory system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-104|5|823|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-105|5|825|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-106|5|826|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-107|5|828|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-108|5|828|Neoplasia malignant|Lower respiratory system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-109|5|829|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-110|5|829|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-111|5|831|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-112|5|834|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-113|5|837|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-114|5|838|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-115|5|844|Neoplasia malignant|Lower respiratory system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-116|5|845|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-117|5|846|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-118|5|849|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-119|5|849|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-120|5|849|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-121|5|850|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-122|5|851|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-123|5|851|Other deterministic changes|Whole body|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-124|5|854|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-125|5|855|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-126|5|856|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-127|5|858|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-128|5|860|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|large cells,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-129|5|860|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-130|5|865|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-131|5|869|Neoplasia malignant|Endocrine system|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-132|5|870|Other deterministic changes|Whole body|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-133|5|871|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-134|5|872|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-135|5|879|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 218 - neoplasm|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-136|5|881|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-137|5|888|Neoplasia malignant|Lower respiratory system|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-138|5|888|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-139|5|889|Neoplasia malignant|Lower respiratory system|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-140|5|889|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-141|5|896|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-142|5|898|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-143|5|899|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-144|5|901|Neoplasia benign|Lower respiratory system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-145|5|901|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-146|5|901|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-147|5|902|Other deterministic changes|Whole body|missing|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-148|5|903|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-149|5|905|Neoplasia malignant|Lower respiratory system|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-150|5|905|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-151|5|907|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-152|5|908|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-153|5|909|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-154|5|909|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-155|5|912|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-156|5|915|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-157|5|915|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-158|5|916|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-159|5|917|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|mast cell proliferation,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-160|5|918|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-161|5|919|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-162|5|921|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-163|5|922|Neoplasia malignant|Lower respiratory system|mucinous tumour|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-164|5|923|Neoplasia malignant|Endocrine system|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-165|5|924|Neoplasia benign|Lower respiratory system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-166|5|927|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-167|5|929|Other deterministic changes|Whole body|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-168|5|930|Neoplasia benign|Lower respiratory system|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-169|5|931|Neoplasia malignant|Liver among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-170|5|931|Other deterministic changes|Whole body|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-171|5|933|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|abscess seminal  vesicle|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-172|5|935|Neoplasia malignant|Lower respiratory system|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-173|5|936|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-174|5|936|Neoplasia benign|Liver among hepato-pancreatic system diseases|lymphocytosis|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-175|5|937|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|small cell,MPATH: 513 - Lymphoid neoplasms|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-176|5|937|Other deterministic changes|Whole body|missing 19.8.91|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-177|5|940|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-178|5|942|Other deterministic changes|Whole body|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-179|5|946|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-180|5|947|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-181|5|949|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-182|5|951|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-183|5|956|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-184|5|956|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-185|5|956|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-186|5|957|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-187|5|957|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-188|5|957|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-189|5|957|Other deterministic changes|Whole body|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-190|5|964|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-191|5|972|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-192|5|978|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-193|5|978|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-194|5|980|Other deterministic changes|Whole body|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-195|5|985|Neoplasia malignant|Liver among hepato-pancreatic system diseases|hyperplastic form|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-196|5|987|Neoplasia benign|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-197|5|1017|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases|metastatic|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-198|5|1025|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-199|5|1034|Neoplasia benign|Liver among hepato-pancreatic system diseases|multiple|
7-5-5|Pu-13d-Bq 64,PLC 6|1| -13|Pu-239 citrate|64|becquerels per g animal|Injection, intravenous| single iv inject.mothers 4d pc|200 (200 in ERA)|Mouse|Mouse, CBA/H|Male|Embryo|offspring|7-5-5-200|5|1045|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus|ulceration small intestine|
		
